US Patent 12109238 Chimeric antigen receptor-modified NK-92 cells
Patent 12109238 was granted and assigned to ImmunityBio on October, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 9 Oct, 2024
Golden AI
Edits made to:
Infobox (+41 properties)
Article (+361 characters)
US Patent 12109238 Chimeric antigen receptor-modified NK-92 cells
Article
Patent abstract
Provided are NK-92 cells expressing a chimeric antigen receptor (CAR). The CAR can comprise an intracellular domain of FcεRIγ. Also described are methods for treating a patient having or suspected of having a disease that is treatable with NK-92 cells, such as cancer or a viral infection, comprising administering to the patient NK-92-CAR cells.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Hans G. Klingemann0
Laurent H. Boissel0
Date of Patent
October 8, 2024
0Patent Application Number
178122640
Date Filed
July 13, 2022
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 12109238 Chimeric antigen receptor-modified NK-92 cells
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
